Janus Henderson Further Cuts PharmEasy's Valuation To $2.7 Bn
India, June 2 -- Global asset management company (AMC) Janus Henderson has further marked down its stake valuation in Mumbai-based online pharmacy PharmEasy's parent company API Holdings.
According to Janus Henderson's regulatory filings with the US Securities and Exchange Commission (SEC), funds managed by the AMC marked the fair value of PharmEasy at $2.7 Bn, less than half of its $5.6 Bn valuation during the fundraise in October 2021.
Janus Henderson has cut the online pharmacy's valuation twice in two weeks, having first marked its valuation to about $2.8 Bn as of December 31, 2022. The investor's move also came days after the New York-based investment firm Neuberger Berman also trimmed the valuation of the epharmacy startup to $4.4...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.